ES2137162T3 - Cefalosporinas y homologos, preparaciones y composiciones farmaceuticas. - Google Patents
Cefalosporinas y homologos, preparaciones y composiciones farmaceuticas.Info
- Publication number
- ES2137162T3 ES2137162T3 ES91913583T ES91913583T ES2137162T3 ES 2137162 T3 ES2137162 T3 ES 2137162T3 ES 91913583 T ES91913583 T ES 91913583T ES 91913583 T ES91913583 T ES 91913583T ES 2137162 T3 ES2137162 T3 ES 2137162T3
- Authority
- ES
- Spain
- Prior art keywords
- approvals
- cephalosporins
- compositions
- pharmaceutical preparations
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ANTIBIOTICOS (BETA)-LACTAM CON LA FORMULA (I) O SU SAL, EN DONDE R1 ES HIDROGENO, METOXI O FORMAMIDA; R2 ES UN GRUPO ACILO; CO2R3 ES UN GRUPO CARBOXI O UN ANION CARBOXILADO O R3 ES UN GRUPO PROTECTOR CARBOXI FACILMENTE SUPRIMIBLE; R4 REPRESENTA HASTA CUATRO SUBSTITUYENTES; X ES S, SO, SO2, O O CH2; M ES 1 O 2; Y N ES 0, UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS EN HUMANOS Y ANIMALES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909016189A GB9016189D0 (en) | 1990-07-24 | 1990-07-24 | Novel compounds |
GB919109540A GB9109540D0 (en) | 1991-05-02 | 1991-05-02 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2137162T3 true ES2137162T3 (es) | 1999-12-16 |
Family
ID=26297372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91913583T Expired - Lifetime ES2137162T3 (es) | 1990-07-24 | 1991-07-22 | Cefalosporinas y homologos, preparaciones y composiciones farmaceuticas. |
Country Status (26)
Country | Link |
---|---|
EP (2) | EP0540606A1 (es) |
JP (2) | JP2851428B2 (es) |
KR (1) | KR100189075B1 (es) |
CN (2) | CN1061046C (es) |
AP (1) | AP832A (es) |
AT (1) | ATE185567T1 (es) |
AU (1) | AU648329B2 (es) |
CA (2) | CA2359744C (es) |
CZ (1) | CZ6493A3 (es) |
DE (2) | DE69131714T2 (es) |
DK (1) | DK0540609T3 (es) |
ES (1) | ES2137162T3 (es) |
FI (1) | FI930270A (es) |
GR (1) | GR3031711T3 (es) |
HU (1) | HUT63628A (es) |
IE (1) | IE912569A1 (es) |
IL (1) | IL98909A0 (es) |
LU (1) | LU91290I2 (es) |
MX (1) | MX9100317A (es) |
MY (1) | MY106399A (es) |
NL (1) | NL300249I1 (es) |
NO (1) | NO930226L (es) |
NZ (1) | NZ239061A (es) |
PT (1) | PT98426A (es) |
WO (2) | WO1992001696A1 (es) |
YU (1) | YU129691A (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9125645D0 (en) * | 1991-12-03 | 1992-01-29 | Smithkline Beecham Plc | Novel compounds |
DE69331047T2 (de) * | 1992-01-22 | 2002-03-21 | Pfizer | 2-isocephem und -oxacephemderivate,verfahren zu deren herstellung, deren zwischenprodukte und verwendung als antibakterielle mittel |
GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
GB9213567D0 (en) * | 1992-06-26 | 1992-08-12 | Smithkline Beecham Plc | Novel compounds |
GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
AU4398297A (en) * | 1996-10-02 | 1998-04-24 | Daiichi Pharmaceutical Co., Ltd. | Method for esterifying carboxylic compounds |
FR2776292B1 (fr) * | 1998-03-20 | 2004-09-10 | Oncopharm | Cephalotaxanes porteurs de chaine laterale et leur procede de synthese |
GB0019124D0 (en) | 2000-08-03 | 2000-09-27 | Pfizer | Novel process |
HUP0400642A3 (en) * | 2000-12-04 | 2010-03-29 | Pfizer Prod Inc | Coupling process and intermediates useful for preparing cephalosphorins |
CA2436863C (en) * | 2000-12-04 | 2007-05-22 | Pfizer Products Inc. | Process and ester derivatives useful for preparation of cephalosporins |
US7378408B2 (en) * | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
KR100710555B1 (ko) | 2001-12-04 | 2007-04-24 | 에스케이 주식회사 | 광학적으로 순수한 (r)-폼 또는 (s)-폼의테트라히드로퓨라닐 케톤의 제조방법 |
CN104114568B (zh) | 2011-12-22 | 2017-09-01 | 艾丽奥斯生物制药有限公司 | 取代的核苷、核苷酸及其类似物 |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
PL2861611T3 (pl) | 2012-05-25 | 2017-08-31 | Janssen Sciences Ireland Uc | Nukleozydy uracylowe spirooksetanu |
EA201590943A1 (ru) | 2012-12-21 | 2016-01-29 | Алиос Биофарма, Инк. | Замещенные нуклеозиды, нуклеотиды и их аналоги |
CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
KR20210057053A (ko) | 2018-08-23 | 2021-05-20 | 씨젠 인크. | 항-tigit 항체 |
AU2020397059A1 (en) | 2019-12-06 | 2022-07-21 | Vertex Pharmaceuticals Incorporated | Substituted tetrahydrofurans as modulators of sodium channels |
TW202322824A (zh) | 2020-02-18 | 2023-06-16 | 美商基利科學股份有限公司 | 抗病毒化合物 |
CN111620893B (zh) * | 2020-06-08 | 2021-12-14 | 重庆医药高等专科学校 | C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法和应用 |
WO2022221514A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
IL308953A (en) | 2021-06-04 | 2024-01-01 | Vertex Pharma | N-Hydroalkyl(Hetero)Aryl)Tetrahydrofuran Carboxamides as Natrene Channel Modulators |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793448A (fr) * | 1971-12-31 | 1973-06-28 | Roussel Uclaf | Procede de preparation de nouveaux derives des cephalosporines et produits obtenus |
FR2197573A1 (en) * | 1972-09-07 | 1974-03-29 | Roussel Uclaf | 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci |
BE791161A (fr) * | 1972-01-03 | 1973-05-09 | Beecham Group Ltd | Procede pour la preparation d'analogues des cephalosporines |
BE791160A (fr) * | 1972-01-03 | 1973-05-09 | Beecham Group Ltd | Nouveaux cephemes substitues |
NL7305936A (es) * | 1972-05-05 | 1973-11-07 | ||
JPS5849382A (ja) * | 1981-09-18 | 1983-03-23 | Kyowa Hakko Kogyo Co Ltd | β−ラクタム化合物 |
GB8821797D0 (en) * | 1988-09-16 | 1988-10-19 | Beecham Group Plc | Novel compounds |
DK0395219T3 (da) * | 1989-03-30 | 1999-02-15 | Pfizer | Cephalosporiner og deres homologer, fremgangsmåde til deres fremstilling og farmaceutiske præparater |
-
1991
- 1991-07-16 MY MYPI91001321A patent/MY106399A/en unknown
- 1991-07-22 HU HU93177A patent/HUT63628A/hu unknown
- 1991-07-22 DE DE69131714T patent/DE69131714T2/de not_active Expired - Lifetime
- 1991-07-22 ES ES91913583T patent/ES2137162T3/es not_active Expired - Lifetime
- 1991-07-22 CZ CS9364A patent/CZ6493A3/cs unknown
- 1991-07-22 EP EP91913545A patent/EP0540606A1/en not_active Withdrawn
- 1991-07-22 IE IE256991A patent/IE912569A1/en not_active IP Right Cessation
- 1991-07-22 NZ NZ239061A patent/NZ239061A/en not_active IP Right Cessation
- 1991-07-22 KR KR1019930700216A patent/KR100189075B1/ko not_active IP Right Cessation
- 1991-07-22 JP JP3512368A patent/JP2851428B2/ja not_active Expired - Lifetime
- 1991-07-22 IL IL98909A patent/IL98909A0/xx unknown
- 1991-07-22 DE DE200612000065 patent/DE122006000065I2/de active Active
- 1991-07-22 JP JP3512255A patent/JPH05509089A/ja active Pending
- 1991-07-22 AP APAP/P/1991/000305A patent/AP832A/en active
- 1991-07-22 CA CA002359744A patent/CA2359744C/en not_active Expired - Lifetime
- 1991-07-22 EP EP91913583A patent/EP0540609B1/en not_active Expired - Lifetime
- 1991-07-22 AT AT91913583T patent/ATE185567T1/de active
- 1991-07-22 AU AU82224/91A patent/AU648329B2/en not_active Expired
- 1991-07-22 DK DK91913583T patent/DK0540609T3/da active
- 1991-07-22 WO PCT/GB1991/001228 patent/WO1992001696A1/en active IP Right Grant
- 1991-07-22 CA CA002087967A patent/CA2087967C/en not_active Expired - Lifetime
- 1991-07-22 MX MX9100317A patent/MX9100317A/es unknown
- 1991-07-22 WO PCT/GB1991/001227 patent/WO1992001695A1/en not_active Application Discontinuation
- 1991-07-23 YU YU129691A patent/YU129691A/sh unknown
- 1991-07-23 PT PT98426A patent/PT98426A/pt not_active Application Discontinuation
- 1991-07-24 CN CN91105783A patent/CN1061046C/zh not_active Expired - Lifetime
-
1993
- 1993-01-22 NO NO93930226A patent/NO930226L/no unknown
- 1993-01-22 FI FI930270A patent/FI930270A/fi unknown
-
1998
- 1998-11-14 CN CN98122407A patent/CN1111410C/zh not_active Expired - Lifetime
-
1999
- 1999-11-03 GR GR990402803T patent/GR3031711T3/el unknown
-
2006
- 2006-11-22 LU LU91290C patent/LU91290I2/fr unknown
- 2006-11-27 NL NL300249C patent/NL300249I1/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2137162T3 (es) | Cefalosporinas y homologos, preparaciones y composiciones farmaceuticas. | |
MX9202896A (es) | Compuestos de 4''-ceto- y 4''-amino-4''-deoxi avermectina y sus derivados amino substituidos. | |
FR2518088B1 (fr) | Nouveaux derives d'aminoacides, et leur application therapeutique | |
BG94837A (bg) | О-метилни производни на азитромицин а, метод за тяхното получаване и приложението им като фармацевтични препарати | |
FI842406A (fi) | Laongverkande kefaklorformulation. | |
ATE184009T1 (de) | Halichondrine: zytotoxische polyäther-makrolide | |
SE8404065D0 (sv) | Novel biologically active compounds | |
IT9019754A0 (it) | Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica | |
NO163331C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer. | |
LV10108A (lv) | Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni | |
ES466037A1 (es) | Un procedimiento para preparar derivados de oleandomicina. | |
FR2666508B1 (fr) | Compositions pharmaceutiques contenant des derives de furanne. | |
DK0406745T3 (da) | Antibiotiske GE 2270 faktorer A1, A2, A3 og H | |
DK0463514T3 (da) | 3,3-Dithiobis-(propionsyrer) og estere heraf | |
DK291390D0 (da) | Terapeutiske anvendelser af 2',5'-oligoadenylatderivater | |
FI874123A (fi) | Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter. | |
IT1216104B (it) | Peptidi ad attivita' farmaceutica. | |
DK0675900T3 (da) | Antibiotika GE 37468 A, B og C | |
BE868590A (fr) | Derives alpha-acetyleniques et alpha-vinyliques d'amino-acides | |
DE68916275D1 (de) | 1-Carbacephalosporin-Antibiotika. | |
NO890287L (no) | Fremstilling av beta-laktam-antibiotika. | |
NO890245L (no) | Isoxazoler med nootrop aktivitet. | |
IT1216103B (it) | Peptidi ad attivita' farmaceutica. | |
ATE19077T1 (de) | Thiophen-derivat mit mucoregulatorischer und anti-husten-wirkung, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen. | |
IT7830125A0 (it) | Associazione di antibiotici caratterizzata da diminuita tossicita', e composizioni farmaceutiche relative. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 540609 Country of ref document: ES |